List of works - Jonathan A McCullers

Community-Acquired Pneumonia Requiring Hospitalization among U.S. Adults

scientific article published on 14 July 2015

Insights into the interaction between influenza virus and pneumococcus

scientific article

Community-acquired pneumonia requiring hospitalization among U.S. children

scientific article

Expression of the 1918 influenza A virus PB1-F2 enhances the pathogenesis of viral and secondary bacterial pneumonia

scientific article

Lethal synergism between influenza virus and Streptococcus pneumoniae: characterization of a mouse model and the role of platelet-activating factor receptor

scientific article

The co-pathogenesis of influenza viruses with bacteria in the lung

scientific article published on March 3, 2014

Role of neuraminidase in lethal synergism between influenza virus and Streptococcus pneumoniae

scientific article published on 6 March 2003

Distinct contributions of vaccine-induced immunoglobulin G1 (IgG1) and IgG2a antibodies to protective immunity against influenza

scientific article

Depletion of Alveolar Macrophages during Influenza Infection Facilitates Bacterial Superinfections

scientific article published on June 26, 2013

Respiratory viruses predisposing to bacterial infections: role of neuraminidase

scientific article published on January 2004

Influenza virus neuraminidase contributes to secondary bacterial pneumonia

scientific article published on 08 June 2005

Influenza enhances susceptibility to natural acquisition of and disease due to Streptococcus pneumoniae in ferrets.

scientific article

N-linked glycosylation attenuates H3N2 influenza viruses

scientific article

T cell receptor αβ diversity inversely correlates with pathogen-specific antibody levels in human cytomegalovirus infection

scientific article published on April 2012

PB1-F2 proteins from H5N1 and 20 century pandemic influenza viruses cause immunopathology

scientific article

Kinetics of coinfection with influenza A virus and Streptococcus pneumoniae

scientific article

Multiple genotypes of influenza B virus circulated between 1979 and 2003.

scientific article published on December 2004

Influenza virus primes mice for pneumonia from Staphylococcus aureus.

scientific article

Effect of antiviral treatment on the outcome of secondary bacterial pneumonia after influenza

scientific article published on 30 June 2004

Novel strategy to prevent otitis media caused by colonizing Streptococcus pneumoniae

scientific article

The effects of influenza A virus PB1-F2 protein on polymerase activity are strain specific and do not impact pathogenesis

scientific article

Treatment with protein synthesis inhibitors improves outcomes of secondary bacterial pneumonia after influenza

scientific article published on February 2009

Does Glycosylation as a modifier of Original Antigenic Sin explain the case age distribution and unusual toxicity in pandemic novel H1N1 influenza?

scientific article

Impaired wound healing predisposes obese mice to severe influenza virus infection

scientific article

Glycan Shielding of the Influenza Virus Hemagglutinin Contributes to Immunopathology in Mice

scientific article published on October 8, 2010

Immunopathogenic and Antibacterial Effects of H3N2 Influenza A Virus PB1-F2 Map to Amino Acid Residues 62, 75, 79, and 82

scientific article published on September 21, 2011

Toll-Like Receptor 2 Mediates Fatal Immunopathology in Mice During Treatment of Secondary Pneumococcal Pneumonia Following Influenza

scientific article published on September 7, 2011

Recipients of vaccine against the 1976 "swine flu" have enhanced neutralization responses to the 2009 novel H1N1 influenza virus

scientific article

Live Attenuated Influenza Vaccine Enhances Colonization of Streptococcus pneumoniae and Staphylococcus aureus in Mice

scientific article published on February 18, 2014

Bacterial sinusitis and otitis media following influenza virus infection in ferrets

scientific article published on May 2006

Fatal Outcome of Pandemic H1N1 2009 Influenza Virus Infection Is Associated with Immunopathology and Impaired Lung Repair, Not Enhanced Viral Burden, in Pregnant Mice

scientific article published on August 24, 2011

Mathematical model of a three-stage innate immune response to a pneumococcal lung infection

scientific article published on February 12, 2011

Effect of 1918 PB1-F2 expression on influenza A virus infection kinetics

scientific article

A multi-valent vaccine approach that elicits broad immunity within an influenza subtype.

scientific article published on 07 January 2009

Association Between Hospitalization With Community-Acquired Laboratory-Confirmed Influenza Pneumonia and Prior Receipt of Influenza Vaccination

scientific article

Contribution of vaccine-induced immunity toward either the HA or the NA component of influenza viruses limits secondary bacterial complications

scientific article

Motivating factors for high rates of influenza vaccination among healthcare workers

scientific article published on June 23, 2011

Preventing and treating secondary bacterial infections with antiviral agents

scientific article

Correlates of vaccine protection from influenza and its complications

scientific article published on January 1, 2012

Fatal influenza B infections: time to reexamine influenza research priorities

scientific article

c-di-GMP is an effective immunomodulator and vaccine adjuvant against pneumococcal infection.

scientific article published on 18 July 2008

Secondary bacterial infections in influenza virus infection pathogenesis.

scientific article published on January 2014

A single amino acid change in the C-terminal domain of the matrix protein M1 of influenza B virus confers mouse adaptation and virulence

scientific article published on June 2005

Eosinophils Promote Antiviral Immunity in Mice Infected with Influenza A Virus

scientific article

Viral suppressors of the RIG-I-mediated interferon response are pre-packaged in influenza virions

scientific article

The novel parainfluenza virus hemagglutinin-neuraminidase inhibitor BCX 2798 prevents lethal synergism between a paramyxovirus and Streptococcus pneumoniae

scientific article

Chloroquine is effective against influenza A virus in vitro but not in vivo

scientific article published on September 2007

Improving therapeutic strategies for secondary bacterial pneumonia following influenza

scientific article

Safety and immunogenicity of live attenuated and inactivated influenza vaccines in children with cancer

scientific article published on 23 September 2011

The immune profile associated with acute allergic asthma accelerates clearance of influenza virus

scientific article

List of works by Jonathan A McCullers

Community-Acquired Pneumonia Requiring Hospitalization among U.S. Adults

Insights into the interaction between influenza virus and pneumococcus

Community-acquired pneumonia requiring hospitalization among U.S. children

Expression of the 1918 influenza A virus PB1-F2 enhances the pathogenesis of viral and secondary bacterial pneumonia

Lethal synergism between influenza virus and Streptococcus pneumoniae: characterization of a mouse model and the role of platelet-activating factor receptor

The co-pathogenesis of influenza viruses with bacteria in the lung

Role of neuraminidase in lethal synergism between influenza virus and Streptococcus pneumoniae

Distinct contributions of vaccine-induced immunoglobulin G1 (IgG1) and IgG2a antibodies to protective immunity against influenza

Depletion of Alveolar Macrophages during Influenza Infection Facilitates Bacterial Superinfections

Respiratory viruses predisposing to bacterial infections: role of neuraminidase

Influenza virus neuraminidase contributes to secondary bacterial pneumonia

Influenza enhances susceptibility to natural acquisition of and disease due to Streptococcus pneumoniae in ferrets.

N-linked glycosylation attenuates H3N2 influenza viruses

T cell receptor αβ diversity inversely correlates with pathogen-specific antibody levels in human cytomegalovirus infection

PB1-F2 proteins from H5N1 and 20 century pandemic influenza viruses cause immunopathology

Kinetics of coinfection with influenza A virus and Streptococcus pneumoniae

Multiple genotypes of influenza B virus circulated between 1979 and 2003.

Influenza virus primes mice for pneumonia from Staphylococcus aureus.

Effect of antiviral treatment on the outcome of secondary bacterial pneumonia after influenza

Novel strategy to prevent otitis media caused by colonizing Streptococcus pneumoniae

The effects of influenza A virus PB1-F2 protein on polymerase activity are strain specific and do not impact pathogenesis

Treatment with protein synthesis inhibitors improves outcomes of secondary bacterial pneumonia after influenza

Does Glycosylation as a modifier of Original Antigenic Sin explain the case age distribution and unusual toxicity in pandemic novel H1N1 influenza?

Impaired wound healing predisposes obese mice to severe influenza virus infection

Glycan Shielding of the Influenza Virus Hemagglutinin Contributes to Immunopathology in Mice

Immunopathogenic and Antibacterial Effects of H3N2 Influenza A Virus PB1-F2 Map to Amino Acid Residues 62, 75, 79, and 82

Toll-Like Receptor 2 Mediates Fatal Immunopathology in Mice During Treatment of Secondary Pneumococcal Pneumonia Following Influenza

Recipients of vaccine against the 1976 "swine flu" have enhanced neutralization responses to the 2009 novel H1N1 influenza virus

Live Attenuated Influenza Vaccine Enhances Colonization of Streptococcus pneumoniae and Staphylococcus aureus in Mice

Bacterial sinusitis and otitis media following influenza virus infection in ferrets

Fatal Outcome of Pandemic H1N1 2009 Influenza Virus Infection Is Associated with Immunopathology and Impaired Lung Repair, Not Enhanced Viral Burden, in Pregnant Mice

Mathematical model of a three-stage innate immune response to a pneumococcal lung infection

Effect of 1918 PB1-F2 expression on influenza A virus infection kinetics

A multi-valent vaccine approach that elicits broad immunity within an influenza subtype.

Association Between Hospitalization With Community-Acquired Laboratory-Confirmed Influenza Pneumonia and Prior Receipt of Influenza Vaccination

Contribution of vaccine-induced immunity toward either the HA or the NA component of influenza viruses limits secondary bacterial complications

Motivating factors for high rates of influenza vaccination among healthcare workers

Preventing and treating secondary bacterial infections with antiviral agents

Correlates of vaccine protection from influenza and its complications

Fatal influenza B infections: time to reexamine influenza research priorities

c-di-GMP is an effective immunomodulator and vaccine adjuvant against pneumococcal infection.

Secondary bacterial infections in influenza virus infection pathogenesis.

A single amino acid change in the C-terminal domain of the matrix protein M1 of influenza B virus confers mouse adaptation and virulence

Eosinophils Promote Antiviral Immunity in Mice Infected with Influenza A Virus

Viral suppressors of the RIG-I-mediated interferon response are pre-packaged in influenza virions

The novel parainfluenza virus hemagglutinin-neuraminidase inhibitor BCX 2798 prevents lethal synergism between a paramyxovirus and Streptococcus pneumoniae

Chloroquine is effective against influenza A virus in vitro but not in vivo

Improving therapeutic strategies for secondary bacterial pneumonia following influenza

Safety and immunogenicity of live attenuated and inactivated influenza vaccines in children with cancer

The immune profile associated with acute allergic asthma accelerates clearance of influenza virus